Grantham, Mayo, Van Otterloo & Co (GMO)’s ArcBest ARCB Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ARCB Stock Details ARCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$662K	Buy	6,728 +1,811	+37%	+$172K	﹤0.01%	542
2025 Q4	$365K	Buy	4,917 +519	+12%	+$36.9K	﹤0.01%	603
2025 Q3	$307K	Buy	4,398 +1,420	+48%	+$107K	﹤0.01%	558
2025 Q2	$229K	Buy	+2,978	New	+$194K	﹤0.01%	586
2025 Q1	–	Sell	-257,060	Closed	-$24M	–	619
2024 Q4	$24M	Buy	257,060 +10,390	+4%	+$1.1M	0.08%	171
2024 Q3	$26.8M	Buy	246,670 +22,590	+10%	+$2.48M	0.08%	165
2024 Q2	$24M	Buy	224,080 +52,844	+31%	+$6.37M	0.08%	165
2024 Q1	$24.4M	Buy	+171,236	New	+$22.4M	0.09%	167
2021 Q1	–	Sell	-57,800	Closed	-$2.47M	–	840
2020 Q4	$2.47M	Sell	57,800 -49,600	-46%	-$1.88M	0.02%	404
2020 Q3	$3.34M	Buy	107,400 +23,400	+28%	+$729K	0.02%	310
2020 Q2	$2.23M	Buy	+84,000	New	+$1.8M	0.02%	390

Other funds holding ARCB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ARCB Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its ArcBest (ARCB) stake by 37% in Q1 2026, buying an estimated $172K and bringing the position to 6,728 shares worth $662K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ARCB in Q2 2020 and has held it in 11 quarters since. The position peaked at $26.8M in Q3 2024. 277 funds tracked by Wall St. Rank hold ARCB as of Q1 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 6,728 shares of ArcBest worth $662K as of Q1 2026.
Grantham, Mayo, Van Otterloo & Co (GMO) bought 1,811 ArcBest shares in Q1 2026, an estimated $172K.
ArcBest made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #542 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ArcBest in Q2 2020 and has held it in 11 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s ArcBest position peaked at $26.8M in Q3 2024.
277 funds tracked by Wall St. Rank held ArcBest as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.